Could healthy skin hold clues to melanoma return?
NCT ID NCT02854124
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study examined whether healthy skin near a melanoma tumor contains hidden cancer stem cells that might predict the disease's return. Researchers analyzed tissue from 226 people with early-stage melanoma to see if these cells are linked to 5-year survival. The goal is to better understand how melanoma spreads and improve prognosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which melanoma patients are at higher risk of recurrence by checking healthy tissue near the tumor.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct change in patient care, and the findings might not apply to all melanoma types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Name:: INSERM - UMRS 938, UPMC Saint-Antoinen Hospital, Team "Stem cells and transition from pre-invasive tumors"
Paris, Paris, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a Six-Month exercise and diet plan shield muscle during melanoma treatment?
- E-Learning could sharpen Doctors' eye for skin cancer
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Can a new drug tame advanced solid tumors?
- Can a One-Two punch of immune boosters revive cancer treatment?